Time-kill Curves for a Semisynthetic Glycopeptide, LY333328, Against Vancomycin-susceptible and Vancomycin-resistant Enterococcus Faecium Strains
Overview
Affiliations
Boylan C, Campanale K, Iversen P, Phillips D, Zeckel M, Parr Jr T Antimicrob Agents Chemother. 2003; 47(5):1700-6.
PMID: 12709343 PMC: 153305. DOI: 10.1128/AAC.47.5.1700-1706.2003.
Zelenitsky S, Booker B, Laing N, Karlowsky J, Hoban D, Zhanel G Antimicrob Agents Chemother. 1999; 43(3):592-7.
PMID: 10049272 PMC: 89165. DOI: 10.1128/AAC.43.3.592.
Saleh-Mghir A, Lefort A, Petegnief Y, Dautrey S, Vallois J, Le Guludec D Antimicrob Agents Chemother. 1998; 43(1):115-20.
PMID: 9869575 PMC: 89030. DOI: 10.1128/AAC.43.1.115.
Garcia-Garrote F, Cercenado E, Alcala L, Bouza E Antimicrob Agents Chemother. 1998; 42(9):2452-5.
PMID: 9736584 PMC: 105854. DOI: 10.1128/AAC.42.9.2452.
Efficacy of LY333328 against experimental methicillin-resistant Staphylococcus aureus endocarditis.
Kaatz G, Seo S, Aeschlimann J, Houlihan H, Mercier R, Rybak M Antimicrob Agents Chemother. 1998; 42(4):981-3.
PMID: 9559828 PMC: 105587. DOI: 10.1128/AAC.42.4.981.